Area of research
Oncology · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, Cancer Cells and Metastasis, Pancreatic and Hepatic Oncology Research, and Lung Cancer Treatments and Mutations.
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
<scp>Ge</scp> N <scp>Nius</scp> : an ultrafast drug–target interaction inference method based on graph neural networks
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis
MEK1/2 Inhibition Elicits Regression of Autochthonous Lung Tumors Induced by KRASG12D or BRAFV600E